Prophylactic and therapeutic methods against histomoniasis in poultry

Histomoniasis, commonly known as blackhead disease, is a parasitic

disease in poultry caused by the protozoan Histomonas meleagridis.

The availability of various compounds for chemotherapy in the 1970s

resulted in the successful control of blackhead disease. Since the ban

of antihistomonal drugs in the European Union, the disease has reemerged, resulting in up to 100% mortality in turkey flocks. This has

renewed the interest of scientists with numerous publications

focusing on prophylactic strategies. This review summarizes the

literature on the preventive and curative options for the control and

treatment of histomoniasis. Two main approaches to the prophylaxis

of the disease were found, which included chemotherapies and plant

substrate products. Histostat-50 and paromomycin were the only

available drugs that showed antihistomonal activity despite some

concern about their threat to human health and antibiotic resistance.

None of the plant substrate products provided potential protection to

birds against blackhead disease. The use of attenuated histomonads

could be an alternative for the prevention of the disease, but the

production of this vaccine prototype is still challenging due to

advanced technique requirements.

Prophylactic and therapeutic methods against histomoniasis in poultry trang 1

Trang 1

Prophylactic and therapeutic methods against histomoniasis in poultry trang 2

Trang 2

Prophylactic and therapeutic methods against histomoniasis in poultry trang 3

Trang 3

Prophylactic and therapeutic methods against histomoniasis in poultry trang 4

Trang 4

Prophylactic and therapeutic methods against histomoniasis in poultry trang 5

Trang 5

Prophylactic and therapeutic methods against histomoniasis in poultry trang 6

Trang 6

Prophylactic and therapeutic methods against histomoniasis in poultry trang 7

Trang 7

Prophylactic and therapeutic methods against histomoniasis in poultry trang 8

Trang 8

Prophylactic and therapeutic methods against histomoniasis in poultry trang 9

Trang 9

Prophylactic and therapeutic methods against histomoniasis in poultry trang 10

Trang 10

Tải về để xem bản đầy đủ

pdf 13 trang xuanhieu 4260
Bạn đang xem 10 trang mẫu của tài liệu "Prophylactic and therapeutic methods against histomoniasis in poultry", để tải tài liệu gốc về máy hãy click vào nút Download ở trên

Tóm tắt nội dung tài liệu: Prophylactic and therapeutic methods against histomoniasis in poultry

Prophylactic and therapeutic methods against histomoniasis in poultry
. 
This indicated that attenuated H. meleagridis did 
not cause any adverse effects to infected chickens 
and turkeys. This was one of a very few studies 
focusing on vaccinations of this parasite in 
chickens. These findings could be useful for 
further investigations in the vaccine development 
for histomoniasis. However, the design of this 
study was not strongly convincing. The authors 
used a dose of only 104 histomonads per bird, 
which was significantly lower than the dose used 
by other scientists, ranging from 1.4x105 to 106 
parasites per bird (Zenner et al., 2003; Hu & 
McDougald, 2004; Hafez & Hauck, 2006; van 
Der Heijden et al., 2008). It could explain why 
no changes were observed in the birds infected 
by attenuated parasites. Further studies are 
required to confirm the effectiveness of the 
immunization produced by these attenuated 
isolates. 
A recent study conducted by Nguyen Pham 
et al. (2013) examined the protective 
effectiveness of the low-virulent H. meleagridis 
against blackhead disease in turkeys. The low-
virulent H. meleagridis was produced by serial 
intracloacal passages, which are also known as 
back passages. The back passage comprised of an 
intracloacal inoculation of histomonad to 3-
week-old birds. Thirteen days post-inoculation, 
these birds were euthanized to obtain the parasite 
for reinoculation of new birds. An examination 
of the virulence of the back passages showed that 
the last three intracloacal passages, did not cause 
any of the typical lesions found in turkeys. 
Subsequently, back passage 10 was used to test 
the protective capacity against H. meleagridis. 
Nguyen Van Phuong & Bui Khanh Linh (2020) 
https://vjas.vnua.edu.vn/ 603 
The birds vaccinated with this low virulent back 
passage yielded minor clinical signs, and lower 
liver and caecal lesion scores compared to the 
unvaccinated challenged group; and no mortality 
compared to 71% in the unvaccinated group in an 
experimental challenge with a virulent strain of 
the parasite. This result indicated that the low-
virulent H. meleagridis attenuated by serial 
intracloacally passages was able to protect 
turkeys from a virulent strain of this parasite. A 
logical experiment design used in this study 
made its findings persuasive. 
In general, most studies evaluating 
histomoniasis vaccination were conducted 
exclusively in turkeys. The transfer of serum 
antibodies from experimentally infected birds 
was unable to protect birds from histomonads 
infection, while active immunization created by 
injecting antigens showed protective activity. 
Several authors proved that a vaccination with in 
vitro attenuated parasites could provide 
protection to turkeys against H. meleagridis 
independently of administration (Table 4). 
Additionally, this type of vaccination did not 
alter the performance of the subjected birds. In a 
practical sense, the production of an effective 
vaccine would require not only sophisticated 
techniques but also a harmonization between 
laboratory experiments and field demand. 
The future of histomoniasis treatments 
Following the ban of nitroimidazoles, 
recognized as high potential antihistomonal 
drugs in the European Union and some other 
countries, due to the concern of ecological and 
human health threats, researchers were forced to 
search for viable alternatives in preventing 
histomoniasis. In general, three different 
approaches were investigated to deal with the 
situation. These were the application of 
antibiotics showing antiprotozoal activity, 
testing plant substances, particularly some 
essential oils, and the attempt to develop 
effective vaccines. 
Among the various drugs tested, Histostat-
50 and Paromomycin are the two available drugs 
in some markets that possess antihistomonal 
activity despite recently raised concerns about 
deleterious side effects such as bacterial 
resistance and consumer safety. It is, therefore, 
crucial for policymakers to strike a balance 
between the benefits of the consumer and the 
sustainability of animal production. 
A large number of plant substances were 
tested for their effectiveness against 
histomoniasis, none of which conferred reliable 
protection to birds in in vivo experiments. There 
was a lack of standardized methodology for 
infection among the studies that led to 
inconsistent results. It is therefore recommended 
to address this issue in further investigations. 
Approaches to different types of 
immunizations showed that only vaccinations 
with attenuated parasites could induce reliable 
protection from histomoniasis in turkeys. 
However, the production of vaccines, 
particularly for this protist, would be challenging 
due to a high level of sophisticated techniques 
required. 
Acknowledgements 
We are grateful for the comments of Dr. Anne 
Beasley at the University of Queensland. She also 
answered numerous questions about the language 
of this paper. We also thank Prof. Nguyen Van Tho 
and Dr. Nguyen Thi Hong Chien, our colleagues 
at the Vietnam National University of Agriculture, 
who also looked over our transcriptions and 
provided valuable comments. 
 Table 4. Literature evaluating the effectiveness of vaccinations in the protection of birds from histomoniasis 
Passive vaccination Active vaccination 
Antigens Inactivated parasite Attenuated parasite 
Bleyen et al. (2009)* Bleyen et al. (2009) Hess et al. (2008)* 
Hess et al. (2008); 
Liebhart et al. (2010); 
Nguyen Pham et al. (2013) 
 Note: * Proved to be ineffective to protect birds from blackhead disease. 
Prophylactic and therapeutic methods against histomoniasis in poultry 
604 Vietnam Journal of Agricultural Sciences 
We acknowledge the insightful comments 
offered by the anonymous reviewers and the hard 
work of the language reviewers who saved us 
from many errors. 
References 
Abraham M., McDougald L. R. & Beckstead R. B. (2014). 
Blackhead disease: Reduced sensitivity of Histomonas 
meleagridis to nitarsone in Vitro and in Vivo. Avian 
diseases. 58(1): 60-63. 
Administration USFaD. FDA. (2015). Announces Pending 
Withdrawal of Approval of Nitarsone. Retrieved from 
https://www.ngfa.org/news/feed-news/fda-announces-
pending-withdrawal-of-nitarsone-for-use-in-turkeys-
chicken/#:~:text=The%20Food%20and%20Drug%20
Administration,by%20the%20end%20of%202015 on 
October 10, 2019. 
Araújo J. L., Olinda R. G., Frade M. T. S., Maia L. Â. & 
Dantas A. F. M. (2015). Histomoniasis outbreak in 
free-range chickens in semiarid Paraíba, Brazil. 
Semina: Ciências Agrárias. 36(1): 307-312. 
Bleyen N., De Gussem K., Nguyen Pham Anh Dao, Ons E., 
Van Gerven N. & Goddeeris B. M. (2009). Non-
curative, but prophylactic effects of paromomycin in 
Histomonas meleagridis-infected turkeys and its effect 
on performance in non-infected turkeys. Veterinary 
Parasitology. 165(3-4): 248-255. 
Bleyen N., Ons E., De Gussem M. & Goddeeris B. M. 
(2009). Passive immunization against Histomonas 
meleagridis does not protect turkeys from an 
experimental infection. Avian Pathology. 38(1): 
71-76. 
Byrne D. (2001). Commission Regulation (EC) No. 
2205/2001 of November 14, 2001 amending Council 
Directive 70/524/EEC concerning additives in 
feedingstuffs as regards withdrawal of the 
authorisation of certain additives 2001. Retrieved from 
https://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=CELEX%3A32001R2205 on 
October 10, 2019. 
Cushman S. (1893). The production of turkeys. Rhode 
Island Agricultural Experiment Station Bulletin. 25: 
89-123. 
Duffy C. F., Sims M. D. & Power R. F. (2005). Evaluation 
of dietary Natustat for control of Histomonas 
meleagridis in male turkeys on infected litter. Avian 
Diseases. 49(3):423-425. 
Duffy C. F., Sims M. D. & Power R. F. (2004). Preliminary 
evaluation of dietary natustat™ versus histostat® 
(Nitarsone) for control of Histomonas meleagridis in 
broiler chickens on infected litter. International 
Journal of Poultry Science. 3(12): 753-757. 
EFSA (2009). Scientific Opinion of the Panel on Additives 
and Products or Substances used in Animal Feed 
(FEEDAP) on a request from the European 
Commission on the preliminary evaluation of the 
safety and efficacy of paromomycin sulphate for 
turkeys for fattening and turkeys reared for breeding. 
The EFSA Journal. 1095: 1-22. 
Esquenet C., De Herdt P., De Bosschere H., Ronsmans S., 
Ducatelle R. & Van Erum J. (2003). An outbreak of 
histomoniasis in free-range layer hens. Avian 
Pathology. 32(3): 305-308. 
Grabensteiner E., Liebhart D., Arshad N. & Hess M. (2008) 
Antiprotozoal activities determined in vitro and in vivo 
of certain plant extracts against Histomonas 
meleagridis, Tetratrichomonas gallinarum and 
Blastocystis sp. Parasitology Research. 103(6): 1257-
1264. 
Grabensteiner E., Liebhart D., Weissenböck H. & Hess M. 
(2006). Broad dissemination of Histomonas 
meleagridis determined by the detection of nucleic 
acid in different organs after experimental infection of 
turkeys and specified pathogen-free chickens using a 
mono-eukaryotic culture of the parasite. Parasitology 
International. 55(4): 317-322. 
Hafez H. M., Schulze D., Hauck R. & Lüschow D. (2005). 
Histomonas meleagridis: The Situation after the Ban 
of the Last Available Drug in the EU. Proceedings of 
the fifty-fourth Western pounltry disease conference. 
Vancouver, B.C., Canada. 
Hafez H.M., Hauck R., Gad W., De Gussem K. & Lotfi A. 
(2010). Pilot study on the efficacy of paromomycin as 
a histomonostatic feed additive in turkey poults 
experimentally infected with Histomonas meleagridis. 
Archives of Animal Nutrition. 64(1): 77-84. 
Hafez H. M. & Hauck R. (2006). Efficacy of a herbal 
product against Histomonas meleagridis after 
experimental infection of turkey poults. Archives of 
Animal Nutrition. 60(5): 436-642. 
Hauck R., Armstrong P. L., Fuller L. & McDougald L. R. 
(2007). The effect of Natustat® on Histomoniasis in 
turkeys. Proceedings of the 56th Western poultry 
disease . March 26-29, 2007. Las Vegas, Nevada. 102-
104. 
Hauck R., Balczulat S. & Hafez H. M. (2010). Detection of 
DNA of Histomonas meleagridis and 
Tetratrichomonas gallinarum in German poultry 
flocks between 2004 and 2008. Avian Diseases. 
54(3): 1021-1025. 
Hess M., Liebhart D., Grabensteiner E. & Singh A. (2008). 
Cloned Histomonas meleagridis passaged in vitro 
resulted in reduced pathogenicity and is capable of 
protecting turkeys from histomonosis. Vaccine. 
26(33): 4187-4193. 
Hu J. & McDougald L. R. (2004). The efficacy of some 
drugs with known antiprotozoal activity against 
Histomonas meleagridis in chickens. Veterinary 
parasitology. 121(3-4): 233-238. 
Kawalek J. C., Carson M., Conklin S., Lancaster V., 
Howard K. & Ward J. (2011). Provide data on various 
arsenic species present in broilers treated with 
Nguyen Van Phuong & Bui Khanh Linh (2020) 
https://vjas.vnua.edu.vn/ 605 
roxarsone: comparison with untreated birds. Final 
report on Study 275.30. 2011. US Food and Drug 
Administration: Laurel, MD, USA. 
Kempf I., Le Roux A., Perrin-Guyomard A., Mourand G., 
Le Devendec L., Bougeard S., Richez P., Le Pottier G. 
& Eterradossi N. (2013). Effect of in-feed 
paromomycin supplementation on antimicrobial 
resistance of enteric bacteria in turkeys. The 
Veterinary Journal. 198(2): 398-403. DOI: 
10.1016/j.tvjl.2013.05.030. 
Liebhart D., Windisch M. & Hess M. (2010). Oral 
vaccination of 1-day-old turkeys with in vitro 
attenuated Histomonas meleagridis protects against 
histomonosis and has no negative effect on 
performance. Avian Pathology. 39(5): 399-403. 
Lund E. E. & Burtner Jr R. H. (1957). Infectivity of 
Heterakis gallinae eggs with Histomonas meleagridis. 
Experimental Parasitology. 6(2):189-93. 
DOI: 10.1016/0014-4894(57)90014-0. 
McDougald L. R. & Fuller L. (2005). Blackhead disease in 
turkeys: direct transmission of Histomonas 
meleagridis from bird to bird in a laboratory model. 
Avian Diseases. 49(3): 328-331. 
McDougald L. R. & Hu J. (2001). Blackhead disease 
(Histomonas meleagridis) aggravated in broiler 
chickens by concurrent infection with cecal coccidiosis 
(Eimeria tenella). Avian Diseases. 45(2): 307-312. 
Nguyen Duc Tan, Bilic I., Jaskulsa B., Hess M. B., Le Duc 
Quyet, Le Hua Ngoc Luc, Huynh Vy Vu, Nguyen Thi 
Sam & Vu Khac Hung (2015). Prevalence and genetic 
characterization of Histomonas meleagridis in 
chickens in Vietnam. Avian diseases. 59(2):309-314. 
DOI: 10.1637/10964-102414-Reg. 
Nguyen Pham Anh Dao., De Gussem J. K. & Goddeeris B. M. 
(2013). Intracloacally passaged low-virulent Histomonas 
meleagridis protects turkeys from histomonosis. 
Veterinary Parasitology. 196(3): 307-313. 
Reece R. L., Beddome V. D. & Barr D. A. (1986). Diseases 
diagnosed in replacement layer and breeder chicken 
flocks in Victoria, Australia, 1977 to 1985. Veterinary 
Record. 119(19): 471-475. 
Somkid K. P. K. & Niwat C. (2006). Outbreak of 
histomoniasis in cross breed native chickens from one 
private farm in Nakorn Pathom province. Retrieved on 
October 18, 2019 from 
search/search.do?recordID=TH2006000328. 
Swayne DEG. J. R., McDougald L. R., Nolan L. K., Suarez 
D. L. & Nair V. (2013). Diseases of Poultry. 13, editor: 
John Wiley & Sons, Inc; 1423. 
van der Heijden H. M. J. F., De Gussem K. & Landman W. 
J. M. (2011). Assessment of the antihistomonal effect 
of paromomycin and tiamulin. Tijdschrift Voor 
Diergeneeskunde. 136(6): 410-416. 
van der Heijden H. M. (2009). Detection, typing and control 
of Histomonas meleagridis. Retrieved from 
42/heijden.pdf?sequence=1 on October 18, 2019. 
van der Heijden H. M. J. F. & Landman W. J. M. (2008a). 
In vitro effect of herbal products against Histomonas 
meleagridis. Veterinary Parasitology. 154(1): 1-7. 
van der Heijden H. M. & Landman W. J. M. (2008b). In 
vivo effect of herbal products against Histomonas 
meleagridis in turkeys. Avian Pathology: journal of the 
WVPA. 37(1): 45-50. 
Waters S. M., Duffy C. F. & Power R. F. G. (2005). PCR-
DGGE analysis of caecal microflora of Natustat™ 
supplemented turkeys challenged with Histomonas 
meleagridis. International Journal of Poultry Science. 
4(9): 620-627. 
Zahoor M. A., Liebhart D. & Hess M. (2011). Progression 
of histomonosis in commercial chickens following 
experimental infection with an in vitro propagated clonal 
culture of Histomonas meleagridis. Avian Diseases. 
55(1): 29-34. DOI: 10.1637/9508-082110-Reg.1. 
Zenner L., Callait M. P., Granier C. & Chauve C. (2003). 
In vitro effect of essential oils from Cinnamomum 
aromaticum, Citrus limon and Allium sativum on two 
intestinal flagellates of poultry, Tetratrichomonas 
gallinarum and Histomonas meleagridis. Parasite. 
10(2): 153-157. DOI: 10.1051/parasite/2003102153. 

File đính kèm:

  • pdfprophylactic_and_therapeutic_methods_against_histomoniasis_i.pdf